BIT
FOLD

BlackRock Institutional Trust’s Amicus Therapeutics FOLD Stock Holding History

BlackRock Institutional Trust’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$18.4M Buy
3,692,098
+247,588
+7% +$1.71M ﹤0.01% 2027
2016
Q3 		$25.5M Buy
3,444,510
+203,942
+6% +$1.38M ﹤0.01% 1705
2016
Q2 		$17.7M Buy
3,240,568
+313,096
+11% +$2.19M ﹤0.01% 1929
2016
Q1 		$24.7M Sell
2,927,472
-47,153
-2% -$334K ﹤0.01% 1667
2015
Q4 		$28.9M Buy
2,974,625
+241,066
+9% +$2.17M ﹤0.01% 1601
2015
Q3 		$38.2M Buy
2,733,559
+849,178
+45% +$13.3M 0.01% 1398
2015
Q2 		$26.7M Buy
1,884,381
+743,025
+65% +$8.93M ﹤0.01% 1719
2015
Q1 		$12.4M Buy
1,141,356
+569,262
+100% +$5.02M ﹤0.01% 2254
2014
Q4 		$4.76M Buy
572,094
+549,807
+2,467% +$3.77M ﹤0.01% 2755
2014
Q3 		$133K Buy
+22,287
New +$117K ﹤0.01% 3654
2014
Q2 		– Sell
-277,718
Closed -$575K – 3966
2014
Q1 		$575K Buy
277,718
+1,253
+0.5% +$3.13K ﹤0.01% 3546
2013
Q4 		$650K Sell
276,465
-39,509
-13% -$86.7K ﹤0.01% 3515
2013
Q3 		$733K Sell
315,974
-28,060
-8% -$70.4K ﹤0.01% 3439
2013
Q2 		$802K Buy
+344,034
New +$1.06M ﹤0.01% 3388

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock Institutional Trust's FOLD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Amicus Therapeutics (FOLD) stake by 7.2% in Q4 2016, buying an estimated $1.71M and bringing the position to 3,692,098 shares worth $18.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

BlackRock Institutional Trust first reported a position in FOLD in Q2 2013 and has held it in 14 quarters since. The position peaked at $38.2M in Q3 2015. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • BlackRock Institutional Trust held 3,692,098 shares of Amicus Therapeutics worth $18.4M as of Q4 2016.
  • BlackRock Institutional Trust bought 247,588 Amicus Therapeutics shares in Q4 2016, an estimated $1.71M.
  • Amicus Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2027 holding.
  • BlackRock Institutional Trust first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 14 quarters since.
  • BlackRock Institutional Trust's Amicus Therapeutics position peaked at $38.2M in Q3 2015.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.